Loading clinical trials...
Loading clinical trials...
The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
NCT06844383 · Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)
NCT06594926 · Prostate Cancer
NCT07177937 · Small Cell Lung Cancer, Melanoma, and more
NCT06926283 · Prostate Cancer, Other Solid Tumors, and more
NCT05919264 · Cancer, Colorectal Cancer, and more
Moffitt Cancer Center
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions